T. Nikitenko , O. Rymar , S. Malyutina , L. Shcherbakova , E. Veryovkin , S. Kurilovich , Yu. Ragino , M. Voevoda
{"title":"P96","authors":"T. Nikitenko , O. Rymar , S. Malyutina , L. Shcherbakova , E. Veryovkin , S. Kurilovich , Yu. Ragino , M. Voevoda","doi":"10.1016/j.ejcsup.2015.08.070","DOIUrl":null,"url":null,"abstract":"<div><p>Obesity, associated with metabolic syndrome, is considered a significant risk factor for colorectal cancer (CRC).</p></div><div><h3>Purpose</h3><p>To compare the levels of metabolic syndrome (MS) components in persons with CRC and control in the frame of nested “case-control” design.</p></div><div><h3>Materials and Methods</h3><p>The study was carried out on the basis of a comparison of databases from epidemiological study The HAPIEE project and CRC register. The patients examined in the HAPIEE project, who had developed CRC during 10-year follow-up period according to the register of cancer (<em>n</em> <!-->=<!--> <!-->92, men-48, women-44, mean age 60.7<!--> <!-->+<!--> <!-->6.9<!--> <!-->years) were included in analysis. The control group, matched by sex and age, was also formed from the HAPIEE database (<em>n</em> <!-->=<!--> <!-->184, men-96, women-88, mean age 60.7<!--> <!-->+<!--> <!-->6.8<!--> <!-->years). We used MS criteria’s according to NCEP ATP – III (2001). The data was processed using statistical program SPSS 13.0.</p></div><div><h3>Results</h3><p>Body mass index (BMI) and waist circumference (WC) had no significant differences in the studied groups, the average BMI value in CRC group was 28.6<!--> <!-->+<!--> <!-->5.3<!--> <!-->kg/m<sup>2</sup> vs 28.4<!--> <!-->+<!--> <!-->5.6<!--> <!-->kg/m<sup>2</sup> in control (<em>p</em> <!-->=<!--> <!-->0.70) and WC value in CRC group was 94.1<!--> <!-->+<!--> <!-->11.7<!--> <!-->cm vs 94.1<!--> <!-->+<!--> <!-->13.6<!--> <!-->cm in control (<em>p</em> <!-->=<!--> <!-->0.90). The percentage of patients with abdominal obesity was 41.3% in patients with CRC vs 42.9% in the control group (<em>p</em> <!-->=<!--> <!-->0.70).</p><p>The average value of total cholesterol was equally high in both groups (246.8<!--> <!-->+<!--> <!-->52.5<!--> <!-->mg/dL in patients with CRC and 239.8<!--> <!-->+<!--> <!-->47.0<!--> <!-->mg/dL in the control group), with large individual variation but no significant difference (<em>p</em> <!-->=<!--> <!-->0.27). The average level of HDL cholesterol in CRC group was within normal limits and also did not differ from control (<em>p</em> <!-->=<!--> <!-->0.60). The average level of TG in CRC patients was slightly lower than in the control group: 127.2<!--> <!-->+<!--> <!-->58.5<!--> <!-->mg/dl vs 144.6<!--> <!-->+<!--> <!-->80.8<!--> <!-->mg/dL (<em>p</em> <!-->=<!--> <!-->0.07). The average level of glucose did not differ in patients with CRC and in control: 5.9<!--> <!-->+<!--> <!-->1,2<!--> <!-->mmol/l vs 6.1<!--> <!-->+<!--> <!-->2.1<!--> <!-->mmol/L (<em>p</em> <!-->=<!--> <!-->0.40). In patients with CRC systolic blood pressure was significantly lower than in control group: 142.1<!--> <!-->+<!--> <!-->21.3<!--> <!-->mmHg vs 150.4<!--> <!-->+<!--> <!-->23.7<!--> <!-->mmHg (<em>p</em> <!-->=<!--> <!-->0.005). The level of diastolic blood pressure was slightly lower than in the control group compared to CRC (88.9<!--> <!-->+<!--> <!-->11.2<!--> <!-->mmHg vs91.9<!--> <!-->+<!--> <!-->13.4<!--> <!-->mmHg, <em>p</em> <!-->=<!--> <!-->0.06). The proportions of patients with low HDL cholesterol, hypertriglyceridemia and hyperglycemia did not differ between the studied groups, but proportion of hypertension among controls was higher compared to the patients with CRC (85.3% vs 69.6% <em>p</em> <!-->=<!--> <!-->0.002).</p></div><div><h3>Conclusions</h3><p>In studied sample, we did not found the differences in the values of anthropometric indicators of metabolic syndrome, cholesterol, HDL cholesterol, triglycerides and glucose between patients with colorectal cancer and control. Systolic and diastolic blood pressure as well as hypertension frequency were significantly lower in CRC group than in the control group. Further analysis including stage and localization of CRC is required.</p><p><em>The HAPIEE project is supported by Wellcome Trust (WT081081AIA).</em></p></div>","PeriodicalId":11675,"journal":{"name":"Ejc Supplements","volume":"13 1","pages":"Pages 39-40"},"PeriodicalIF":0.0000,"publicationDate":"2015-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejcsup.2015.08.070","citationCount":"0","resultStr":"{\"title\":\"P96\",\"authors\":\"T. Nikitenko , O. Rymar , S. Malyutina , L. Shcherbakova , E. Veryovkin , S. Kurilovich , Yu. Ragino , M. Voevoda\",\"doi\":\"10.1016/j.ejcsup.2015.08.070\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Obesity, associated with metabolic syndrome, is considered a significant risk factor for colorectal cancer (CRC).</p></div><div><h3>Purpose</h3><p>To compare the levels of metabolic syndrome (MS) components in persons with CRC and control in the frame of nested “case-control” design.</p></div><div><h3>Materials and Methods</h3><p>The study was carried out on the basis of a comparison of databases from epidemiological study The HAPIEE project and CRC register. The patients examined in the HAPIEE project, who had developed CRC during 10-year follow-up period according to the register of cancer (<em>n</em> <!-->=<!--> <!-->92, men-48, women-44, mean age 60.7<!--> <!-->+<!--> <!-->6.9<!--> <!-->years) were included in analysis. The control group, matched by sex and age, was also formed from the HAPIEE database (<em>n</em> <!-->=<!--> <!-->184, men-96, women-88, mean age 60.7<!--> <!-->+<!--> <!-->6.8<!--> <!-->years). We used MS criteria’s according to NCEP ATP – III (2001). The data was processed using statistical program SPSS 13.0.</p></div><div><h3>Results</h3><p>Body mass index (BMI) and waist circumference (WC) had no significant differences in the studied groups, the average BMI value in CRC group was 28.6<!--> <!-->+<!--> <!-->5.3<!--> <!-->kg/m<sup>2</sup> vs 28.4<!--> <!-->+<!--> <!-->5.6<!--> <!-->kg/m<sup>2</sup> in control (<em>p</em> <!-->=<!--> <!-->0.70) and WC value in CRC group was 94.1<!--> <!-->+<!--> <!-->11.7<!--> <!-->cm vs 94.1<!--> <!-->+<!--> <!-->13.6<!--> <!-->cm in control (<em>p</em> <!-->=<!--> <!-->0.90). The percentage of patients with abdominal obesity was 41.3% in patients with CRC vs 42.9% in the control group (<em>p</em> <!-->=<!--> <!-->0.70).</p><p>The average value of total cholesterol was equally high in both groups (246.8<!--> <!-->+<!--> <!-->52.5<!--> <!-->mg/dL in patients with CRC and 239.8<!--> <!-->+<!--> <!-->47.0<!--> <!-->mg/dL in the control group), with large individual variation but no significant difference (<em>p</em> <!-->=<!--> <!-->0.27). The average level of HDL cholesterol in CRC group was within normal limits and also did not differ from control (<em>p</em> <!-->=<!--> <!-->0.60). The average level of TG in CRC patients was slightly lower than in the control group: 127.2<!--> <!-->+<!--> <!-->58.5<!--> <!-->mg/dl vs 144.6<!--> <!-->+<!--> <!-->80.8<!--> <!-->mg/dL (<em>p</em> <!-->=<!--> <!-->0.07). The average level of glucose did not differ in patients with CRC and in control: 5.9<!--> <!-->+<!--> <!-->1,2<!--> <!-->mmol/l vs 6.1<!--> <!-->+<!--> <!-->2.1<!--> <!-->mmol/L (<em>p</em> <!-->=<!--> <!-->0.40). In patients with CRC systolic blood pressure was significantly lower than in control group: 142.1<!--> <!-->+<!--> <!-->21.3<!--> <!-->mmHg vs 150.4<!--> <!-->+<!--> <!-->23.7<!--> <!-->mmHg (<em>p</em> <!-->=<!--> <!-->0.005). The level of diastolic blood pressure was slightly lower than in the control group compared to CRC (88.9<!--> <!-->+<!--> <!-->11.2<!--> <!-->mmHg vs91.9<!--> <!-->+<!--> <!-->13.4<!--> <!-->mmHg, <em>p</em> <!-->=<!--> <!-->0.06). The proportions of patients with low HDL cholesterol, hypertriglyceridemia and hyperglycemia did not differ between the studied groups, but proportion of hypertension among controls was higher compared to the patients with CRC (85.3% vs 69.6% <em>p</em> <!-->=<!--> <!-->0.002).</p></div><div><h3>Conclusions</h3><p>In studied sample, we did not found the differences in the values of anthropometric indicators of metabolic syndrome, cholesterol, HDL cholesterol, triglycerides and glucose between patients with colorectal cancer and control. Systolic and diastolic blood pressure as well as hypertension frequency were significantly lower in CRC group than in the control group. Further analysis including stage and localization of CRC is required.</p><p><em>The HAPIEE project is supported by Wellcome Trust (WT081081AIA).</em></p></div>\",\"PeriodicalId\":11675,\"journal\":{\"name\":\"Ejc Supplements\",\"volume\":\"13 1\",\"pages\":\"Pages 39-40\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2015-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.ejcsup.2015.08.070\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ejc Supplements\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1359634915000713\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ejc Supplements","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1359634915000713","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Obesity, associated with metabolic syndrome, is considered a significant risk factor for colorectal cancer (CRC).
Purpose
To compare the levels of metabolic syndrome (MS) components in persons with CRC and control in the frame of nested “case-control” design.
Materials and Methods
The study was carried out on the basis of a comparison of databases from epidemiological study The HAPIEE project and CRC register. The patients examined in the HAPIEE project, who had developed CRC during 10-year follow-up period according to the register of cancer (n = 92, men-48, women-44, mean age 60.7 + 6.9 years) were included in analysis. The control group, matched by sex and age, was also formed from the HAPIEE database (n = 184, men-96, women-88, mean age 60.7 + 6.8 years). We used MS criteria’s according to NCEP ATP – III (2001). The data was processed using statistical program SPSS 13.0.
Results
Body mass index (BMI) and waist circumference (WC) had no significant differences in the studied groups, the average BMI value in CRC group was 28.6 + 5.3 kg/m2 vs 28.4 + 5.6 kg/m2 in control (p = 0.70) and WC value in CRC group was 94.1 + 11.7 cm vs 94.1 + 13.6 cm in control (p = 0.90). The percentage of patients with abdominal obesity was 41.3% in patients with CRC vs 42.9% in the control group (p = 0.70).
The average value of total cholesterol was equally high in both groups (246.8 + 52.5 mg/dL in patients with CRC and 239.8 + 47.0 mg/dL in the control group), with large individual variation but no significant difference (p = 0.27). The average level of HDL cholesterol in CRC group was within normal limits and also did not differ from control (p = 0.60). The average level of TG in CRC patients was slightly lower than in the control group: 127.2 + 58.5 mg/dl vs 144.6 + 80.8 mg/dL (p = 0.07). The average level of glucose did not differ in patients with CRC and in control: 5.9 + 1,2 mmol/l vs 6.1 + 2.1 mmol/L (p = 0.40). In patients with CRC systolic blood pressure was significantly lower than in control group: 142.1 + 21.3 mmHg vs 150.4 + 23.7 mmHg (p = 0.005). The level of diastolic blood pressure was slightly lower than in the control group compared to CRC (88.9 + 11.2 mmHg vs91.9 + 13.4 mmHg, p = 0.06). The proportions of patients with low HDL cholesterol, hypertriglyceridemia and hyperglycemia did not differ between the studied groups, but proportion of hypertension among controls was higher compared to the patients with CRC (85.3% vs 69.6% p = 0.002).
Conclusions
In studied sample, we did not found the differences in the values of anthropometric indicators of metabolic syndrome, cholesterol, HDL cholesterol, triglycerides and glucose between patients with colorectal cancer and control. Systolic and diastolic blood pressure as well as hypertension frequency were significantly lower in CRC group than in the control group. Further analysis including stage and localization of CRC is required.
The HAPIEE project is supported by Wellcome Trust (WT081081AIA).
期刊介绍：
EJC Supplements is an open access companion journal to the European Journal of Cancer. As an open access journal, all published articles are subject to an Article Publication Fee. Immediately upon publication, all articles in EJC Supplements are made openly available through the journal''s websites.
EJC Supplements will consider for publication the proceedings of scientific symposia, commissioned thematic issues, and collections of invited articles on preclinical and basic cancer research, translational oncology, clinical oncology and cancer epidemiology and prevention.
Authors considering the publication of a supplement in EJC Supplements are requested to contact the Editorial Office of the EJC to discuss their proposal with the Editor-in-Chief.
EJC Supplements is an official journal of the European Organisation for Research and Treatment of Cancer (EORTC), the European CanCer Organisation (ECCO) and the European Society of Mastology (EUSOMA).
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
